Synthesis and antioxidant properties of novel N-methyl-1,3,4-thiadiazol-2-amine and 4-methyl-2 H-1,2,4-triazole-3(4 H)-thione derivatives of benzimidazole class
Nowadays antioxidants arouse researchers’ interest in both medical plants and synthetic compounds. In this study, we synthesized some novel benzimidazole compounds bearing alkyl (methyl) group at the 4th position of triazole ring and at the 5th position of thiadiazole ring instead of aryl group. Som...
Saved in:
Published in | Bioorganic & medicinal chemistry Vol. 16; no. 8; pp. 4294 - 4303 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Ltd
2008
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Nowadays antioxidants arouse researchers’ interest in both medical plants and synthetic compounds. In this study, we synthesized some novel benzimidazole compounds bearing alkyl (methyl) group at the 4th position of triazole ring and at the 5th position of thiadiazole ring instead of aryl group.
Some novel 1-methyl-4-(2-(2-substitutedphenyl-1
H-benzimidazol-1-yl)acetyl)thiosemicarbazides (
16a–
20a), 5-[(2-(substitutedphenyl)-1
H-benzimidazol-1-yl)methyl]-
N-methyl-1,3,4-thiadiazol-2-amines (
17b–
20b), and 5-[(2-(substitutedphenyl)-1
H-benzimidazol-1-yl)methyl-4-methyl-2
H-1,2,4-triazole-3(4
H)-thiones (
16c–
20c) were synthesized and tested for antioxidant properties by using various in vitro systems. Compounds
16a–
20a were found to be a good scavenger of DPPH radical (IC
50, 26
μM; IC
50, 30
μM; IC
50, 43
μM; IC
50, 55
μM; IC
50, 74
μM, respectively) when compared to BHT (IC
50, 54
μM). Noteworthy results could not be found on superoxide radical. Compound
19b, which is the most active derivative inhibited slightly lipid peroxidation (28%) at 10
−3
M concentration. Compound
17c inhibited the microsomal ethoxyresorufin
O-deethylase (EROD) activity with an IC
50
=
4.5
×
10
−4
M which is similarly better than the specific inhibitor caffeine IC
50
=
5.2
×
10
−4
M. |
---|---|
ISSN: | 0968-0896 1464-3391 |
DOI: | 10.1016/j.bmc.2008.02.077 |